New potential treatment for diabetes, with the participation of Mind the Byte
August 17th, 2017 | by Mind the Byte
Type 2 diabetes (T2D) is a complex disease caused by the interaction of genetic and environmental factors. It happens when
August 17th, 2017 | by Mind the Byte
Type 2 diabetes (T2D) is a complex disease caused by the interaction of genetic and environmental factors. It happens when
July 10th, 2017 | by Mind the Byte
Our equity crowdfunding campaign is now officially over and we are so proud of what we have achieved together! We
July 5th, 2017 | by Mind the Byte
Mind the Byte has successfully released a new version of the SaaS platform for computational drug design. This new release
July 5th, 2017 | by Mind the Byte
We are delighted in welcoming Prof Peter Edman as a new member of the Board of Directors of Mind the
June 5th, 2017 | by Mind the Byte
Mind the Byte continues to reinforce its international presence. To this end, Thomas Högberg is joining the company as Business
May 22nd, 2017 | by Mind the Byte
Mind the Byte is to participate for second consecutive year in the Bio IT World fair, which this time will